Clinical Trial Update: Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial assessing lenalidomide plus dexamethasone in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED